ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen

Merdol Ibrahim, Suzanne Parry, Dawn Wilkinson, Neil Bilbe, David Allen, Steven Forrest, Perry Maxwell, Anthony O'Grady, Jane Starczynski, Philippe Tanier, John Gosney, Keith Kerr, Keith Miller, Erik Thunnissen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2241-2247
JournalJournal of Thoracic Oncology
Volume11
Issue number12
DOIs
Publication statusPublished - Dec 2016

Cite this

Ibrahim, M., Parry, S., Wilkinson, D., Bilbe, N., Allen, D., Forrest, S., ... Thunnissen, E. (2016). ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen. Journal of Thoracic Oncology, 11(12), 2241-2247. https://doi.org/10.1016/j.jtho.2016.07.012